Engineered plya protein variants for targeted insect and nematode pest control

Overview

This research program focuses on engineering the PlyA protein component of pleurotolysin (Ply), a naturally occurring pore-forming toxin from the edible oyster mushroom. Ply has demonstrated larvicidal activity against agricultural pests including Western corn rootworm and Colorado potato beetle. The Ply system consists of two proteins: PlyA, which binds to specific lipid molecules in cell membranes, and PlyB, which assembles into lytic pores. By engineering PlyA variants with customized lipid-binding specificity, this technology aims to create targeted biocontrol agents that selectively kill pest insects and nematodes while remaining inactive against human cells.

The core value proposition is a directed evolution approach to develop PlyA variants that recognize pest-specific lipid signatures, enabling precise targeting of agricultural pests. This represents a biologically derived alternative to conventional chemical pesticides, with potential applications in crop protection and integrated pest management.

Technical specifications

Core technology:

• Protein engineering of the PlyA membrane-binding component using directed evolution and synthetic combinatorial libraries
• Structural understanding of PlyA and PlyB monomers at atomic resolution, plus unpublished pore-state structures bound to lipids
• Established screening pipelines for classifying variant membrane-binding and targeting properties

Key capabilities:

• Lipid binding specificity can be modified through mutagenesis to recognize different membrane lipid compositions
• Pore formation is driven by PlyB assembly on the PlyA lipid-binding scaffold, with at least two known PlyA variants (OlyA and OlyA6) demonstrated to initiate pore formation
• Activity measurement uses liposome rupture assays and surface plasmon resonance spectroscopy
• Toxicity testing planned against larvae of important insect pests and nematodes through collaborative validation

Differentiators:

• Structural and kinetic understanding of pleurotolysin assembly mechanism
• Refined methods for mutagenesis, expression, and lipid binding characterization
• Focus on developing variants with no cross-reactivity to human lipids

Technology readiness level

This technology is currently at an early-to-mid stage of development. The research team has established foundational understanding through published and unpublished atomic-resolution structures of PlyA, PlyB, and the assembled pore complex. A library of PlyA variants has been developed to study factors governing pore formation and lipid binding. Biophysical validation methods are operational, including liposome rupture assays and surface plasmon resonance spectroscopy.

Future validation will proceed through three stages: (1) generating diverse PlyA variant populations via directed evolution and combinatorial libraries, (2) screening variants through established pipelines for membrane binding classification, and (3) testing toxicity against target pest larvae through collaborative studies. The technology has not yet reached commercial deployment and requires further development to confirm pest-specific activity and safety profiles before agricultural application.